Cases & Deals

Truffle Capital forms Truffle BioMedTech Crossover Fund

Clients Truffle Capital SAS

Jones Day represented Truffle Capital SAS in connection with the formation and fundraising of Truffle BioMedTech Crossover Fund, a €85 million (US$102 million) medical device and biotechnology venture fund that aims to close at €200 million later in 2018.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.